NEW CANCER STRATEGY - APOPTOSIS BASED THERAPY BY GROWTH-FACTORS (REVIEW)

  • Authors:
    • Y MURAYAMA
    • Y MISHIMA
  • View Affiliations

  • Published online on: January 1, 1995     https://doi.org/10.3892/or.2.1.13
  • Pages: 13-16
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Both epidermal growth factor (EGF) and transforming growth factor type-beta1 (TGF-beta1) have positive and negative growth effects on cell growth. In this review, signal transduction of EGF and TGF-beta1 from their receptor to cell cycle or apoptosis is reviewed and discussed. New evidence that high concentration of EGF induces apoptosis in breast and esophageal cancer in vivo is reported. p53 and RB gene is emphasized as a key gene in induction of cell cycle progression and apoptosis. This review indicates that apoptosis based therapy by EGF and TGF-beta1 is a useful cancer strategy.

Related Articles

Journal Cover

January 1995
Volume 2 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
MURAYAMA Y and MURAYAMA Y: NEW CANCER STRATEGY - APOPTOSIS BASED THERAPY BY GROWTH-FACTORS (REVIEW). Oncol Rep 2: 13-16, 1995
APA
MURAYAMA, Y., & MURAYAMA, Y. (1995). NEW CANCER STRATEGY - APOPTOSIS BASED THERAPY BY GROWTH-FACTORS (REVIEW). Oncology Reports, 2, 13-16. https://doi.org/10.3892/or.2.1.13
MLA
MURAYAMA, Y., MISHIMA, Y."NEW CANCER STRATEGY - APOPTOSIS BASED THERAPY BY GROWTH-FACTORS (REVIEW)". Oncology Reports 2.1 (1995): 13-16.
Chicago
MURAYAMA, Y., MISHIMA, Y."NEW CANCER STRATEGY - APOPTOSIS BASED THERAPY BY GROWTH-FACTORS (REVIEW)". Oncology Reports 2, no. 1 (1995): 13-16. https://doi.org/10.3892/or.2.1.13